Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Mitochondrial Junction Region as Genotyping Marker for Cyclospora cayetanensis.

Nascimento FS, Barta JR, Whale J, Hofstetter JN, Casillas S, Barratt J, Talundzic E, Arrowood MJ, Qvarnstrom Y.

Emerg Infect Dis. 2019 Jul;25(7):1314-1319. doi: 10.3201/eid2507.181447.

2.

Genotyping genetically heterogeneous Cyclospora cayetanensis infections to complement epidemiological case linkage.

Barratt JLN, Park S, Nascimento FS, Hofstetter J, Plucinski M, Casillas S, Bradbury RS, Arrowood MJ, Qvarnstrom Y, Talundzic E.

Parasitology. 2019 Sep;146(10):1275-1283. doi: 10.1017/S0031182019000581. Epub 2019 Jun 20.

PMID:
31148531
3.

Evolution and Genetic Diversity of the k13 Gene Associated with Artemisinin Delayed Parasite Clearance in Plasmodium falciparum.

Pacheco MA, Kadakia ER, Chaudhary Z, Perkins DJ, Kelley J, Ravishankar S, Cranfield M, Talundzic E, Udhayakumar V, Escalante AA.

Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e02550-18. doi: 10.1128/AAC.02550-18. Print 2019 Aug.

PMID:
31085516
4.

Using the Plasmodium mitochondrial genome for classifying mixed-species infections and inferring the geographical origin of P. falciparum parasites imported to the U.S.

Schmedes SE, Patel D, Kelley J, Udhayakumar V, Talundzic E.

PLoS One. 2019 Apr 30;14(4):e0215754. doi: 10.1371/journal.pone.0215754. eCollection 2019.

5.

Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria and prevalence of Pfk13 and Pfmdr1 polymorphisms after a decade of using artemisinin-based combination therapy in mainland Tanzania.

Ishengoma DS, Mandara CI, Francis F, Talundzic E, Lucchi NW, Ngasala B, Kabanywanyi AM, Mahende MK, Kamugisha E, Kavishe RA, Muro F, Mohamed A, Mandike R, Mkude S, Chacky F, Paxton L, Greer G, Kitojo CA, Njau R, Martin T, Venkatesan M, Warsame M, Halsey ES, Udhayakumar V.

Malar J. 2019 Mar 21;18(1):88. doi: 10.1186/s12936-019-2730-1.

6.

Purification of Cyclospora cayetanensis oocysts obtained from human stool specimens for whole genome sequencing.

Qvarnstrom Y, Wei-Pridgeon Y, Van Roey E, Park S, Srinivasamoorthy G, Nascimento FS, Moss DM, Talundzic E, Arrowood MJ.

Gut Pathog. 2018 Oct 12;10:45. doi: 10.1186/s13099-018-0272-7. eCollection 2018.

7.

Restriction enzyme digestion of host DNA enhances universal detection of parasitic pathogens in blood via targeted amplicon deep sequencing.

Flaherty BR, Talundzic E, Barratt J, Kines KJ, Olsen C, Lane M, Sheth M, Bradbury RS.

Microbiome. 2018 Sep 17;6(1):164. doi: 10.1186/s40168-018-0540-2.

8.

Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017.

Davlantes E, Dimbu PR, Ferreira CM, Florinda Joao M, Pode D, Félix J, Sanhangala E, Andrade BN, Dos Santos Souza S, Talundzic E, Udhayakumar V, Owens C, Mbounga E, Wiesner L, Halsey ES, Martins JF, Fortes F, Plucinski MM.

Malar J. 2018 Apr 3;17(1):144. doi: 10.1186/s12936-018-2290-9.

9.

Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2015.

Ljolje D, Dimbu PR, Kelley J, Goldman I, Nace D, Macaia A, Halsey ES, Ringwald P, Fortes F, Udhayakumar V, Talundzic E, Lucchi NW, Plucinski MM.

Malar J. 2018 Feb 20;17(1):84. doi: 10.1186/s12936-018-2233-5.

10.

Next-Generation Sequencing and Bioinformatics Protocol for Malaria Drug Resistance Marker Surveillance.

Talundzic E, Ravishankar S, Kelley J, Patel D, Plucinski M, Schmedes S, Ljolje D, Clemons B, Madison-Antenucci S, Arguin PM, Lucchi NW, Vannberg F, Udhayakumar V.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02474-17. doi: 10.1128/AAC.02474-17. Print 2018 Apr.

11.

Emergence and Spread of kelch13 Mutations Associated with Artemisinin Resistance in Plasmodium falciparum Parasites in 12 Thai Provinces from 2007 to 2016.

Kobasa T, Talundzic E, Sug-Aram R, Boondat P, Goldman IF, Lucchi NW, Dharmarak P, Sintasath D, Fukuda M, Whistler T, MacArthur J, Udhayakumar V, Prempree P, Chinanonwait N.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02141-17. doi: 10.1128/AAC.02141-17. Print 2018 Apr.

12.

Posttreatment HRP2 Clearance in Patients with Uncomplicated Plasmodium falciparum Malaria.

Plucinski MM, Dimbu PR, Fortes F, Abdulla S, Ahmed S, Gutman J, Kachur SP, Badiane A, Ndiaye D, Talundzic E, Lucchi N, Aidoo M, Udhayakumar V, Halsey E, Rogier E.

J Infect Dis. 2018 Feb 14;217(5):685-692. doi: 10.1093/infdis/jix622.

PMID:
29220497
13.

Capacity Development through the US President's Malaria Initiative-Supported Antimalarial Resistance Monitoring in Africa Network.

Halsey ES, Venkatesan M, Plucinski MM, Talundzic E, Lucchi NW, Zhou Z, Mandara CI, Moonga H, Hamainza B, Beavogui AH, Kariuki S, Samuels AM, Steinhardt LC, Mathanga DP, Gutman J, Denon YE, Uwimana A, Assefa A, Hwang J, Shi YP, Dimbu PR, Koita O, Ishengoma DS, Ndiaye D, Udhayakumar V.

Emerg Infect Dis. 2017 Dec;23(13). doi: 10.3201/eid2313.170366.

14.

Molecular diagnosis of Plasmodium ovale by photo-induced electron transfer fluorogenic primers: PET-PCR.

Akerele D, Ljolje D, Talundzic E, Udhayakumar V, Lucchi NW.

PLoS One. 2017 Jun 22;12(6):e0179178. doi: 10.1371/journal.pone.0179178. eCollection 2017.

15.

First Full Draft Genome Sequence of Plasmodium brasilianum.

Talundzic E, Ravishankar S, Nayak V, Patel DS, Olsen C, Sheth M, Batra D, Loparev V, Vannberg FO, Udhayakumar V, Barnwell JW.

Genome Announc. 2017 Feb 9;5(6). pii: e01566-16. doi: 10.1128/genomeA.01566-16.

16.

Efficacy of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015.

Plucinski MM, Dimbu PR, Macaia AP, Ferreira CM, Samutondo C, Quivinja J, Afonso M, Kiniffo R, Mbounga E, Kelley JS, Patel DS, He Y, Talundzic E, Garrett DO, Halsey ES, Udhayakumar V, Ringwald P, Fortes F.

Malar J. 2017 Feb 2;16(1):62. doi: 10.1186/s12936-017-1712-4.

17.

Molecular Epidemiology of Plasmodium falciparum kelch13 Mutations in Senegal Determined by Using Targeted Amplicon Deep Sequencing.

Talundzic E, Ndiaye YD, Deme AB, Olsen C, Patel DS, Biliya S, Daniels R, Vannberg FO, Volkman SK, Udhayakumar V, Ndiaye D.

Antimicrob Agents Chemother. 2017 Feb 23;61(3). pii: e02116-16. doi: 10.1128/AAC.02116-16. Print 2017 Mar.

18.

Evaluation of library preparation methods for Illumina next generation sequencing of small amounts of DNA from foodborne parasites.

Nascimento FS, Wei-Pridgeon Y, Arrowood MJ, Moss D, da Silva AJ, Talundzic E, Qvarnstrom Y.

J Microbiol Methods. 2016 Nov;130:23-26. doi: 10.1016/j.mimet.2016.08.020. Epub 2016 Aug 21.

PMID:
27553132
19.

Advanced Molecular Detection of Malarone Resistance.

Talundzic E, Plucinski MM, Biliya S, Silva-Flannery LM, Arguin PM, Halsey ES, Barnwell JW, Vannberg F, Udhayakumar V.

Antimicrob Agents Chemother. 2016 May 23;60(6):3821-3. doi: 10.1128/AAC.00171-16. Print 2016 Jun.

20.

Independent Emergence of the Plasmodium falciparum Kelch Propeller Domain Mutant Allele C580Y in Guyana.

Chenet SM, Akinyi Okoth S, Huber CS, Chandrabose J, Lucchi NW, Talundzic E, Krishnalall K, Ceron N, Musset L, Macedo de Oliveira A, Venkatesan M, Rahman R, Barnwell JW, Udhayakumar V.

J Infect Dis. 2016 May 1;213(9):1472-5. doi: 10.1093/infdis/jiv752. Epub 2015 Dec 21.

PMID:
26690347
21.

Genetic Analysis and Species Specific Amplification of the Artemisinin Resistance-Associated Kelch Propeller Domain in P. falciparum and P. vivax.

Talundzic E, Chenet SM, Goldman IF, Patel DS, Nelson JA, Plucinski MM, Barnwell JW, Udhayakumar V.

PLoS One. 2015 Aug 20;10(8):e0136099. doi: 10.1371/journal.pone.0136099. eCollection 2015.

22.

Reply to "no robust evidence of lumefantrine resistance".

Plucinski MM, Talundzic E, Morton L, Dimbu PR, Macaia AP, Fortes F, Goldman I, Lucchi N, Stennies G, MacArthur JR, Udhayakumar V.

Antimicrob Agents Chemother. 2015 Sep;59(9):5867-8. doi: 10.1128/AAC.01355-15. No abstract available.

23.

Correction: selection and spread of artemisinin-resistant alleles in Thailand prior to the global artemisinin resistance containment campaign.

Talundzic E, Okoth SA, Congpuong K, Plucinski MM, Morton L, Goldman IF, Kachur PS, Wongsrichanalai C, Satimai W, Barnwell JW, Udhayakumar V.

PLoS Pathog. 2015 Apr 22;11(4):e1004862. doi: 10.1371/journal.ppat.1004862. eCollection 2015 Apr. No abstract available.

24.

Selection and spread of artemisinin-resistant alleles in Thailand prior to the global artemisinin resistance containment campaign.

Talundzic E, Okoth SA, Congpuong K, Plucinski MM, Morton L, Goldman IF, Kachur PS, Wongsrichanalai C, Satimai W, Barnwell JW, Udhayakumar V.

PLoS Pathog. 2015 Apr 2;11(4):e1004789. doi: 10.1371/journal.ppat.1004789. eCollection 2015 Apr. Erratum in: PLoS Pathog. 2015 Apr;11(4):e1004862.

25.

Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and Uíge Provinces, angola.

Plucinski MM, Talundzic E, Morton L, Dimbu PR, Macaia AP, Fortes F, Goldman I, Lucchi N, Stennies G, MacArthur JR, Udhayakumar V.

Antimicrob Agents Chemother. 2015 Jan;59(1):437-43. doi: 10.1128/AAC.04181-14. Epub 2014 Nov 3.

26.

Field evaluation of the photo-induced electron transfer fluorogenic primers (PET) real-time PCR for the detection of Plasmodium falciparum in Tanzania.

Talundzic E, Maganga M, Masanja IM, Peterson DS, Udhayakumar V, Lucchi NW.

Malar J. 2014 Jan 27;13:31. doi: 10.1186/1475-2875-13-31.

27.

Sequence polymorphism, segmental recombination and toggling amino acid residues within the DBL3X domain of the VAR2CSA placental malaria antigen.

Talundzic E, Shah S, Fawole O, Owino S, Moore JM, Peterson DS.

PLoS One. 2012;7(2):e31565. doi: 10.1371/journal.pone.0031565. Epub 2012 Feb 9.

28.

Comparative genomics of four closely related Clostridium perfringens bacteriophages reveals variable evolution among core genes with therapeutic potential.

Oakley BB, Talundzic E, Morales CA, Hiett KL, Siragusa GR, Volozhantsev NV, Seal BS.

BMC Genomics. 2011 Jun 1;12(1):282. doi: 10.1186/1471-2164-12-282.

Supplemental Content

Loading ...
Support Center